Explore every episode of the podcast The Lancet Rheumatology in conversation with
| Title | Pub. Date | Duration | |
|---|---|---|---|
| Coziana Ciurtin on long-term outcomes of childhood-onset Sjögren’s disease | 23 Feb 2026 | 00:35:48 | |
In this month’s episode we discuss childhood-onset Sjögren’s disease-a rare and under-researched rheumatic condition. Click here to read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00283-8/fulltext ----------------------------------------------- Medical imaging and theranostics are revolutionising how we diagnose, treat, and understand disease. To meet this moment, The Lancet group is happy to announce the launch of, The Lancet Medical Imaging and Theranostics. You can visit https://www.thelancet.com/medical-imaging-theranostics to learn more. Continue this conversation on social! | |||
| Fiona Pearce and Rachel Tattersall on HLH mortality rates in Europe | 26 Jan 2026 | 00:34:36 | |
This months episode covers Hemophagocytic lymphohistiocytosis, or HLH, a rare, life-threatening disorder characterised by dysregulated immune activity resulting in systemic inflammation, tissue damage and multiorgan failure which affects both children and adults. Click here to read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00292-9/fulltext Continue this conversation on social! | |||
| Fabian Müller and Melanie Hagen on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy | 03 Jun 2025 | 00:20:50 | |
This is the third and final episode of our mini-series on cell-based therapies in rheumatology, with Professor Fabian Müller and Dr Melanie Hagen from the Erlangen University, Germany. We discuss their recently published a study on a newly discovered toxicity of CD-19 targeting CAR T-cell therapy in patients with autoimmune disease, as well as the recent successes of CAR T-cell therapy, ideal patient selection, and future directions. Read the full article: Continue this conversation on social! | |||
| Dominique Farge on allogeneic umbilical cord-derived mesenchymal stromal cells for systemic lupus erythematosus | 25 Apr 2025 | 00:26:05 | |
This is the second episode of a mini series on cell-based therapies in rheumatology, with Prof. Dominique Farge discussing the use of allogeneic umbilical cord-derived mesenchymal stromal cells (MSCs) as treatment for systemic lupus erythematosus (SLE). We cover the limited options currently available for people with severe or refractory SLE, the complexities in using MSCs, Prof. Farge's recent study results, and how these results fit in with the evidence available, as well as the future for this area of research. You can find the study here: Continue this conversation on social! | |||
| Rebecca Marsh and Grant Schulert on allogeneic HSCT for children with refractory sJIA and associated lung disease | 24 Mar 2025 | 00:18:30 | |
The first episode of a mini series on cell-based therapies in rheumatology, with Prof Rebecca Marsh and Grant Schulert discussing the use of allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease. Read the full article: Continue this conversation on social! | |||
| Bryant England on advanced therapies in US veterans with rheumatoid arthritis-associated interstitial lung disease | 24 Feb 2025 | 00:08:30 | |
Dr Bryant England discusses the use of TNF-inhibitor versus non-TNF inhibitor biological or targeted synthetic DMARDs for treatment of rheumatoid arthritis-associated ILD, and the effects on survival and respiratory hospitalisation outcomes. Read the full article: Continue this conversation on social! | |||
| Brooke Conley and Ivan Lin on the development of arthritis educational resources for Aboriginal and Torres Strait Islander peoples in Australia | 27 Jan 2025 | 00:18:30 | |
Dr Brooke Conley and Associate Professor Ivan Lin discuss their recent study on integrating evidence from lived experience of Aboriginal people and clinical practice guidelines to develop arthritis educational resources. Continue this conversation on social! | |||
| Mark Russell and Sherry Yang on the inequities in rheumatological care in the UK and USA | 23 Dec 2024 | 00:25:28 | |
Dr Mark Russell and Sherry Yang discuss the factors influencing initiation of biologics in underserved populations with rheumatoid arthritis in the UK, how historical redlining and present-day racialised economic segregation affects health-care utilisation of adults with rheumatic diseases in the USA, and health inequities seen in rheumatology more broadly. Continue this conversation on social! | |||
| Quirine Dumoulin on the 4-year data from the TREAT-EARLIER trial | 25 Nov 2024 | 00:15:38 | |
Dr Quirine Dumoulin discusses the efficacy of a 1-year course of methotrexate on the development of rheumatoid arthritis in ACPA-negative people with clinically suspect arthralgia and predicted increased risk of rheumatoid arthritis. Continue this conversation on social! | |||
| Sebastian Sattui on older adults with ANCA-associated vasculitis | 21 Oct 2024 | 00:25:54 | |
Dr Sebastian Sattui discusses the effects of age and frailty on the risks of end-stage renal disease, death, and severe infection in older adults with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Continue this conversation on social! | |||
| Celebrating 5 years of The Lancet Rheumatology with Oliver Distler, Laura Coates, and David Liew | 23 Sep 2024 | 00:58:02 | |
To celebrate 5 years of The Lancet Rheumatology, international advisory board members Oliver Distler, Laura Coates, and David Liew discuss recent progress made, challenges to overcome, and future directions in rheumatology. Continue this conversation on social! | |||
| Karen Schreiber, Ian Giles, and Angela Tincani on the Pregnancy and Rheumatic Diseases Series | 22 Jul 2024 | 00:34:33 | |
Dr Karen Schreiber, Professor Ian Giles, and Professor Angela Tincani discuss the Series on Pregnancy and Rheumatic Diseases, including the use of DMARDs during pregnancy, study design and conduct, and outcomes for children born to mothers with rheumatic diseases. Continue this conversation on social! | |||
| John Isaacs and Josh Bennett on sarcopenia in rheumatoid arthritis | 15 Dec 2025 | 00:19:25 | |
During this episode, Dr John Isaacs and Dr Josh Bennett from Newcastle University and the NIHR Newcastle Biomedical Research Centre, discuss sarcopenia - an age-related loss of muscle mass and strength. Sarcopenia is relatively common in rheumatoid arthritis, with a prevalence ranging from 4·5% to 44% of people with rheumatoid arthritis, depending on the definition of sarcopenia used. Rheumatoid sarcopenia increases the risk of fall, fractures, disability, and hospitalisation. Therefore, prevention and management is important, especially in older patients. We discuss the how and why sarcopenia arises and how it can be managed, as well as the recent publication of the RAMUS study, which looked at the skeletal muscle effects of JAK inhibitor tofacitinib in rheumatoid arthritis. The link to the Nature Rheumatology Review mentioned can also be found below. Continue this conversation on social! | |||
| Dr Maria Tektonidou on cardiovascular risk factors in systemic lupus erythematosus | 17 Jun 2024 | 00:11:20 | |
Dr Maria Tektonidou discusses the results of a cross-sectional analysis of international data on cardiovascular risk factors in systemic lupus erythematosus. Continue this conversation on social! | |||
| Rosemary Hollick on improving services for adults with rare autoimmune rheumatic diseases | 21 May 2024 | 00:16:17 | |
Dr Rosemary Hollick, University of Aberdeen, discusses a mixed-methods study on key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases. Continue this conversation on social! | |||
| Clinical Realities: Heather Van Epps, Anna Clark, Lola Falasinnu, David Liew, and Puja Mehta | 18 Jan 2023 | 00:25:35 | |
Editors Heather Van Epps and Anna Clark join guest hosts Lola Falasinnu, David Liew, and Puja Mehta to reflect on the progress of The Lancet Rheumatology and share their vision for the future. Continue this conversation on social! | |||
| Clinical Realities: Sex and Gender in Research Design and Reporting from The Lancet Summit | 12 Oct 2022 | 00:38:53 | |
Dr Shirin Heidari, Prof James Wason, Dr Karen Schreiber, and Prof Cheryl Barnabe join guest host Dr David Liew to discuss how sex and gender impact research design and reporting and improvements that can be made. Continue this conversation on social! | |||
| Clinical Realities: Randy Cron, Chandrika Bhat, and Puja Mehta | 25 Aug 2022 | 00:33:07 | |
Drs. Randy Cron and Chandrika Bhat join guest host Dr Puja Mehta to discuss the opportunities and challenges of cross-speciality research. Continue this conversation on social! | |||
| Clinical Realities: Michael Weisman and Lola Falasinnu | 28 Jul 2022 | 00:35:20 | |
Prof Michael Weisman joins guest host Dr Lola Falasinnu to discuss the challenges of conducting clinical trials in rheumatology and recent developments in trial design. Continue this conversation on social! | |||
| Clinical Realities: Catherine Nelson-Piercy and Lizemarie Wium on obstetric medicine in rheumatic diseases | 23 Jun 2022 | 00:31:40 | |
Prof Catherine Nelson-Piercy and Dr Lizemarie Wium join guest host Dr Puja Mehta to discuss the importance and challenges of obstetric medicine in rheumatic diseases. Continue this conversation on social! | |||
| Clinical Realities: Greta Lindenmayer, Stephen Brady, and Onika Paolucci on caring for Australian Aboriginal patients with lupus | 31 May 2022 | 00:36:42 | |
Greta Lindenmayer, Stephen Brady, and Onika Paolucci join guest host David Liew to discuss specialist considerations for the care of Australian Aboriginal patients with lupus. Continue this conversation on social! | |||
| Clinical Realities: Duncan Porter and Shahir Hamdulay discuss challenges facing UK rheumatology care in 2022 | 25 Apr 2022 | 00:29:08 | |
Clinical Realities: Duncan Porter and Shahir Hamdulay discuss the challenges facing rheumatology care in the UK in 2022, and what's needed to improve care in the coming years. Continue this conversation on social! | |||
| Clinical Realities: Thomas Bush and Lola Falasinnu on the health consequences of climate hazards for patients with rheumatic diseases | 24 Mar 2022 | 00:23:34 | |
Dr. Thomas Bush joins guest host Dr. Lola Falasinnu to discuss climate change and the potential adverse health effects of climate hazards for patients with rheumatic diseases. Continue this conversation on social! | |||
| Dr Samuel Bitoun on machine learning to classify the focus score and Sjögren's disease | 17 Nov 2025 | 00:11:12 | |
This month's episode covers Sjögren’s disease—an autoimmune condition that primarily affects areas of the body that produce fluids, such as tears and saliva. The cause of the disease isn’t understood. Currently there are no licensed drugs to treat the disease, but phase 2 clinical trials have reported encouraging results, and phase 3 trials are underway. Click here to read the full article: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00181-X/fulltext Continue this conversation on social! | |||
| Clinical Realities: Coziana Ciurtin, Kate Webb, and Puja Mehta on transitional care for adolescent patients with rheumatic diseases | 24 Feb 2022 | 00:31:20 | |
Dr. Coziana Ciurtin and Dr. Kate Webb join guest host Dr. Puja Mehta to discuss the challenges and opportunities involved in transitional care for adolescent patients with rheumatic diseases as they progress to adulthood. Continue this conversation on social! | |||
| Clinical Realities: Dzifa Dey and David Liew on specialist rheumatology care in Ghana | 27 Jan 2022 | 00:29:26 | |
Dr. Dzifa Dey joins guest host Dr. David Liew to discuss innovations in providing specialist rheumatology care and patient education in Ghana, and how her experiences in Africa could help inform development of rheumatology care in other low-resource settings. Continue this conversation on social! | |||
| Clinical Realities: Eric Peters and Jinoos Yazdani on rheumatology care for undocumented immigrants | 22 Dec 2021 | 00:23:29 | |
Dr. Eric Peters and Prof. Jinoos Yazdani join Editor-in-Chief Heather Van Epps to discuss the challenges of providing specialist rheumatology care to undocumented immigrants in the USA. Continue this conversation on social! | |||
| Ryan Hum on synovial immunopathology in psoriatic arthritis | 20 Oct 2025 | 00:26:48 | |
In today's episode, Sophie discusses psoriatic arthritis with Dr Ryan Hum from The University of Manchester. The Review discussed can be found here: https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(25)00231-0/fulltext Continue this conversation on social! | |||
| Scott Uhlrich on personalised gait retraining for knee osteoarthritis | 22 Sep 2025 | 00:16:26 | |
In this episode, we’re tackling a condition that affects over 374 million people worldwide—knee osteoarthritis (OA). As the most common site of OA, knee OA is a leading cause of disability and accounts for more than 12 million disability-adjusted life years globally. With prevalence rising steadily due to aging populations and increasing obesity rates, the burden of knee OA is projected to climb even further in the coming decades. Read the full article: Continue this conversation on social! | |||
| Mark Hancock on low back pain | 18 Aug 2025 | 00:10:20 | |
In this episode, we'll be discussing an issue that affects millions of people globally - low back pain. We will find out why the burden of low back pain is so high, why current management is so ineffective, what we can do from a research and care perspective to improve outcomes for patients, and whether prevention is the way forward. We’ll also discuss a couple of papers that have been recently published in The Lancet Rheumatology looking at longer-term treatment options for low back pain, and how useful they are. Read the Systematic Review: Continue this conversation on social! | |||
| Vibeke Strand on polymyalgia rheumatica | 21 Jul 2025 | 00:11:32 | |
In this episode Professor Vibeke Strand discusses polymyalgia rheumatica (or PMR), a common inflammatory rheumatic disease that significantly impairs patients’ quality of life, causing fatigue, pain, and physical disability, especially in relapsing cases that often require long-term glucocorticoid treatment. However, these treatments come with considerable side effects, and many patients do not respond to treatment. We also cover her recent publication, which explores the patient reported outcomes of a trial using sarilumab, a monoclonal antibody targeting the inflammatory cytokine IL-6, which has now been approved for treatment of PMR in the USA. Read the full article: Continue this conversation on social! | |||
| Xue Li on access to biologics in the Asia-Pacific region | 20 Jun 2025 | 00:19:31 | |
This is a joint podcast between The Lancet Rheumatology and The Lancet Regional Health - Western Pacific with Prof Xue Li. Biologics have become a mainstay of treatment in Rheumatology in Western populations, but in many parts of Asia, especially lower-and-middle-income countries, there remains substantial inequity in access due to differences in availability and affordability. Read the full article: Continue this conversation on social! | |||
| Sinisa Savic on treatment outcomes in VEXAS syndrome | 16 Jun 2025 | 00:12:07 | |
In this podcast, Professor Savic talks about his recent publication that looks at treatment outcomes in patients with VEXAS syndrome, as well as what clinicians should look out for in patients (red flags), and future priorities for research. Read the full article: Continue this conversation on social! | |||